US 9975878
Substituted triazine BMI-1 inhibitors
granted A61KA61K31/53A61K31/5377
Quick answer
US patent 9975878 (Substituted triazine BMI-1 inhibitors) held by PTC THERAPEUTICS, INC. expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/53, A61K31/5377, A61K45/06